Scrip M&A Podcast: Why Has M&A Activity Ramped Downward In 2024?

Scrip’s Joseph Haas discusses biopharma M&A topics such as why deal activity declined during Q2 and Q3 with Gerardo Ubaghs of Frontier Medicines and Jason Silvers of Generate Biomedicines

Scrip Podcast Special
Scrip M&A Podcast on this year's M&A downturn

More from Scrip

More from Podcasts